STRIVE Reporting
STRIVE is a randomised community trial to control sexually transmitted infections in remote Aboriginal communities in northern and central Australia.
Objectives of STRIVE:
- Primary:
- To determine whether targeted clinical review and support provided to health services can achieve substantive and sustained improvements in the provision of sexual health clinical services in remote Aboriginal communities.
- To determine whether the attainment of best practice levels in clinical activity can reduce the prevalence of STIs in these communities.
- Secondary:
- To measure the impact of the STRIVE trial on health service staff.
- To measure other non-STRIVE activities which may influence sexual health service delivery.
Reports are distributed to participating health services as required.
To be included in the STRIVE reporting:
- STI screening must be recorded using the clinical item STI Screening STATE with an export code of STI-SCR.
- Screenings for asymptomatic patients should have the first STI signs and symptoms qualifier set to Asymptomatic.
- Pathology requests must be for tests found using the keyword of STI.
- Abnormal results must be recorded using the Yes/No qualifiers for the specific infection, for example, Chlamydia result abnormal. These are offered in the pathology review if either the lab returns a known code or the result is matched to one of the known tests.
- Treatment must be recorded using the clinical item STI Screening STATE with an export code of STI-TRT.
- In all cases as much information as is required on the screening or treatment items should be provided.
- The reports at make reasonable attempts to find the data relating to a screening, pathology request, result, result review, treatment and subsequent screening. The time sequence is not always linear and not always complete.